Very recently, we identified reduced expression of the NKG2 family of C-type lectin receptors (CD94/NKG2A, CD94/NKG2C, and NKG2D) in CML patients at diagnosis (12). This evidence concerns the gene KLRK1 and chronic myelogenous leukemia, BCR-ABL1 positive.